E. William St. Clair

33.1k citations

170 papers · 16.5k indexed · 5 hit papers · h-index 55

Impact in

Rheumatology top 0.02%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 95
- Systemic Lupus Erythematosus Research 48
- Rheumatoid Arthritis Research and Therapies 48
Genetics 30
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 18

Co-authors: Ravinder N. Maini Paul Emery Peter E. Lipsky Daniel E. Fürst Michael H. Weisman Joachim R. Kalden Désirée van der Heijde Marc Feldmann
Journals: Arthritis & Rheumatology (13 papers)Annals of the Rheumatic Diseases (9 papers)Arthritis Care & Research (7 papers)The Journal of Immunology (4 papers)Annals of Internal Medicine (4 papers)
Partner nations: United States Netherlands United Kingdom

In The Last Decade

E. William St. Clair

169 papers receiving 15.9k citations

Hit Papers

5 papers align trajectories log scale

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells 2010 · 877 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Blood
2005 Science
2004 Arthritis & Rheumatism
2000 New England Journal of Medicine
1999 The Lancet

Peers

Countries citing papers authored by E. William St. Clair

Since Specialization

Citations

This map shows the geographic impact of E. William St. Clair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. William St. Clair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. William St. Clair more than expected).

Fields of papers citing papers by E. William St. Clair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. William St. Clair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. William St. Clair. The network helps show where E. William St. Clair may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. William St. Clair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. William St. Clair Line = papers co-authored together E. William St. Clair links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial Nature Medicine ·E. William St. Clair, Alan N. Baer, Wan‐Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K. Tarrant, Athena Papas, Valérie Devauchelle‐Pensec, Liangwei Wang, Wenjing Xu, Tuyet‐Hang Pham, Keith A. Sikora, William A. Rees, Ilias Alevizos	2024	21
2	Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3 Arthritis & Rheumatology ·Marta Casal Moura, Daniel Cobos Muñoz, Darlene R. Nelson, Lynn A. Fussner, Amber M. Hummel, Dieter E. Jenne, Daniel Emerling, Fernando C. Fervenza, Cees G. M. Kallenberg, Carol A. Langford, W. Joseph McCune, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert Spiera, E. William St. Clair, Steven R. Ytterberg, John H. Stone, William H. Robinson, Ulrich Specks	2022	1
3	Using Parallel Streams of Evidence to Inform Guideline Development: The Case of the 2021 American College of Rheumatology Management of Rheumatoid Arthritis Guideline ACR Open Rheumatology ·Sally Yaacoub, Assem M. Khamis, Mounir Al‐Gibbawi, Lara A Kahale, Joan M. Bathon, Bryant R. England, Liana Fraenkel, E. William St. Clair, Amy S. Turner, Elie A. Akl	2021	3
4	Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial Annals of the Rheumatic Diseases ·Alan N. Baer, Jacques‐Eric Gottenberg, E. William St. Clair, Takayuki Sumida, Tsutomu Takeuchi, Raphaèle Séror, Gary N. Foulks, Marleen Nys, Sumanta Mukherjee, Robert Wong, Neelanjana Ray, Hendrika Bootsma	2020	81
5	Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis JCI Insight ·Kasia Owczarczyk, Matthew D. Cascino, Cécile Holweg, Gaik W. Tew, Ward Ortmann, Timothy W. Behrens, Thomas H. Schindler, Carol A. Langford, E. William St. Clair, Peter A. Merkel, Robert Spiera, Philip Seo, Cees G. M. Kallenberg, Ulrich Specks, Noha Lim, John H. Stone, Paul Brunetta, Marco Prunotto	2020	9
6	Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Arthritis & Rheumatology ·Alvise Berti, Roscoe L. Warner, Kent J. Johnson, Divi Cornec, Darrell R. Schroeder, Brian Kabat, Carol A. Langford, Gary S. Hoffman, Muhammad Najamudin, Cees G. M. Kallenberg, Philip Seo, Robert Spiera, E. William St. Clair, Paul Brunetta, John H. Stone, Dimitrios Panagiotopoulos, Ulrich Specks, Paul A. Monach	2018	48
7	Efficacy Of Glucocorticoids To Treat Limited Flares In ANCA-Associated Vasculitis Data Archiving and Networked Services (DANS) ·Eli M. Miloslavsky, Ulrich Specks, Peter A. Margolis, Philip Seo, Robert Spiera, Carol A. Langford, (unknown), (unknown), E. William St. Clair, Nadia K. Tchao, Linna Ding, David Iklé, Brett Jepson, (unknown), John H. Stone	2013	1
8	Relationship Between Markers of Platelet Activation and Inflammation with Disease Activity in Wegener’s Granulomatosis The Journal of Rheumatology ·Gunnar Tómasson, Michael P. LaValley, Kahraman Tanrıverdi, Javier D. Finkielman, John C. Davis, Gary S. Hoffman, W. Joseph McCune, E. William St. Clair, Ulrich Specks, Robert Spiera, John H. Stone, Jane E. Freedman, Peter A. Merkel	2011	39
9	Alpha₁‐antitrypsin deficiency–related alleles Z and S and the risk of Wegener's granulomatosis Arthritis & Rheumatism ·Alfred Mahr, Jeffrey C. Edberg, John H. Stone, Gary S. Hoffman, E. William St. Clair, Ulrich Specks, Paul F. Dellaripa, Philip Seo, Robert Spiera, Farshid N. Rouhani, Mark Brantly, Peter A. Merkel	2010	62
10	B Cell Depletion Delays Collagen-Induced Arthritis in Mice: Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity The Journal of Immunology ·Koichi Yanaba, Yasuhito Hamaguchi, Guglielmo M. Venturi, Douglas A. Steeber, E. William St. Clair, Thomas F. Tedder	2007	124
11	Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial Arthritis & Rheumatism ·Josef S Smolen, Désirée van der Heijde, E. William St. Clair, Paul Emery, Joan M. Bathon, Edward Keystone, Ravinder N. Maini, Joachim R. Kalden, Michael Schiff, Daniel Baker, Chenglong Han, John Han, Mohan Bala, (unknown)	2006	342
12	New Therapeutics in Rheumatoid Arthritis Rheumatic Disease Clinics of North America ·Christine Savage, E. William St. Clair	2006	8
13	Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET) Arthritis & Rheumatism ·Philip Seo, Yuan‐I Min, Janet T. Holbrook, Gary S. Hoffman, Peter A. Merkel, Robert Spiera, John C. Davis, Steven R. Ytterberg, E. William St. Clair, W. Joseph McCune, Ulrich Specks, Nancy B. Allen, Raashid Luqmani, John H. Stone	2005	140
14	Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1α-889 C/T polymorphism Human Immunology ·Christine G. Parks, Janardan P. Pandey, Mary Anne Dooley, Edward L. Treadwell, E. William St. Clair, Gary S. Gilkeson, Carol Feghali‐Bostwick, Hassene Tmar	2004	54
15	Infliximab treatment for rheumatic disease: clinical and radiological efficacy Annals of the Rheumatic Diseases ·E. William St. Clair	2002	32
16	Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease Clinical Immunology ·Joseph C. Shanahan, E. William St. Clair	2002	65
17	A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score Arthritis & Rheumatism ·John H. Stone, Gary S. Hoffman, Peter A. Merkel, Yuan‐I Min, O. I. Kushnerov, David B. Hellmann, Ulrich Specks, Nancy B. Allen, John C. Davis, Robert Spiera, Leonard H. Calabrese, Fredrick M. Wigley, N Maiden, R. Valente, John L. Niles, Erika Yazmin Gantiva Rodríguez, Joseph W. McCune, E. William St. Clair, Raashid Luqmani, (unknown)	2001	352
18	Interleukin-10: Therapeutic Prospects in Rheumatoid Arthritis PubMed ·E. William St. Clair	2000	6
19	THE USE OF ANALGESICS IN THE MANAGEMENT OF PAIN IN RHEUMATIC DISEASES Rheumatic Disease Clinics of North America ·Larry W. Moreland, E. William St. Clair	1999	10
20	Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome The American Journal of Medicine ·David L. Simel, E. William St. Clair, J. Hartel, Charles S. Greenberg	1987	38

About E. William St. Clair

E. William St. Clair is a scholar working on Rheumatology, Genetics, Immunology, Hematology and Pulmonary and Respiratory Medicine, having authored 170 papers that have together received 16.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (50 papers), Systemic Lupus Erythematosus Research (48 papers), Rheumatoid Arthritis Research and Therapies (48 papers), Monoclonal and Polyclonal Antibodies Research (26 papers), T-cell and B-cell Immunology (25 papers), Autoimmune and Inflammatory Disorders Research (19 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers) and Sarcoidosis and Beryllium Toxicity Research (17 papers). The work is most often cited by research in Rheumatology (9.1k citations), Hematology (3.2k citations), Immunology (5.3k citations), Genetics (2.3k citations) and Virology (463 citations). E. William St. Clair has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Ravinder N. Maini, Paul Emery, Peter E. Lipsky, Daniel E. Fürst, Michael H. Weisman, Joachim R. Kalden, Désirée van der Heijde, Marc Feldmann, Gregory R. Harriman and Ferdinand C. Breedveld. Their work appears in journals such as Arthritis & Rheumatology, Annals of the Rheumatic Diseases, Arthritis Care & Research, The Journal of Immunology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact